Calcium and Sodium Transport in Smooth Muscle

平滑肌中的钙和钠转运

基本信息

  • 批准号:
    6891562
  • 负责人:
  • 金额:
    $ 37.13万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1990
  • 资助国家:
    美国
  • 起止时间:
    1990-07-01 至 2007-05-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by the applicant): This proposal focuses on the hypothesis that Na+ transport is crucial for Ca2+ regulation in vascular smooth muscle cells (VSMC). This is due to localization of key Na+ and Ca2+ transporters in plasma membrane (PM) micro-domains and adjacent (sub-PM) "junctional" sarcoplasmic reticulum (JSR), including PM Na+ pump a2/ct3 isoforms, Na/Ca exchangers (NCX), store-operated channels (SOCs), and some SR Ca2+ pumps (SERCA). Three specific aims are proposed to test the hypothesis: 1) To determine the organization of SR Ca2+ stores and PM-SR junctions in cultured VSMC, and how this influences Ca2+ signaling. How do inhibition of Na+ pump a2/a3 subunits, L-type Ca2+ channels (LVGCs), SOCs, and NCX, affect sub-PM (SPM) and "bulk" cytosolic Ca2+ concentrations ([Ca2+] spm and [Ca2+] cyt) in resting and agonist-stimulated, primary cultured rat VSMC? High resolution, imaging with Ca2+ dyes, Fura 2, Furaptra and FFP-18 (near-membrane indicator), will be used to measure, respectively, global, SR, and Spm [Ca2+], and to elucidate the sites of origin and mechanism(s) of propagation of agonist-evoked Ca2+ signals. Specific transporter isoforms expressed in VSMC will be identified (PCR, immunoblot) and localized by immunocytochemistry in the same cells used to study Ca2+, to relate signal initiation sites to transporter location. Cells with reduced transporter levels, from antisense (AS-) oligo treatment or mice with null mutations will also be examined. These studies will test the idea that a2/a3 Na+ pumps and NCX modulate Ca+ signaling by regulating indirectly local [ca2+] in the space between the PM and jSR (i.e., [ca2+]spm), and Ca2+ storage and release. 2) To determine how SR Ca2+ stores are organized, and which transporters contribute to Ca2+ regulation in VSM within intact about 250pm O.D. arteries. And 3) To determine how Na+ and Ca2+ transporters contribute to myogenic and agonist-evoked constriction in these arteries. Diameter will be monitored and cytosolic and SR Ca2+ will be measured with confocal microscopy using high-and low-affinity Ca2+ dyes, Fluo-4 and Fluo-5N, in isolated, pressurized arteries. The presence and properties of the NCX, LVGCs, SOCs, and IP3- and RY-sensitive Ca2+ stores will be determined. How these transporters influence Ca2+ stores and signaling in individual cells, and how they contribute to myogenic tone and agonist-evoked arterial constriction, will be investigated. Normal arteries and those with reduced transporter levels, from AS-oligo treatment or mice with null mutations, will be examined. Ca2+ signals will be correlated with contraction to elucidate relationships among Na+ pumps, Ca2+ transients and vascular tone, to obtain novel insight into mechanisms that control blood flow and pressure.
描述(由申请方提供):该提案侧重于Na+转运对血管平滑肌细胞(VSMC)中Ca 2+调节至关重要的假设。这是由于质膜(PM)微域和相邻(亚PM)“交界”肌浆网(JSR)中关键Na+和Ca 2+转运蛋白的定位,包括PM Na+泵α 2/α 3亚型、Na/Ca交换剂(NCX)、储存操纵通道(SOC)和一些SR Ca 2+泵(SERCA)。我们提出了三个具体的目标来验证这一假设:1)确定培养的VSMC中SR钙库和PM-SR连接的组织结构,以及这如何影响钙信号。抑制Na+泵a2/a3亚单位、L型钙通道(LVGCs)、SOC和NCX如何影响静息和激动剂刺激的原代培养大鼠VSMC中亚PM(SPM)和“本体”胞浆Ca 2+浓度([Ca 2 +] spm和[Ca 2 +] cyt)? 将使用高分辨率的Ca 2+染料Fura 2、Furaptra和FFP-18(近膜指示剂)成像,分别测量全局、SR和Spm [Ca 2 +],并阐明激动剂诱发的Ca 2+信号的起源部位和传播机制。将鉴定(PCR,免疫印迹)VSMC中表达的特异性转运蛋白亚型,并通过免疫细胞化学在用于研究Ca 2+的相同细胞中进行定位,以将信号起始位点与转运蛋白位置联系起来。还将检查来自反义(AS-)寡核苷酸处理的转运蛋白水平降低的细胞或具有无效突变的小鼠。这些研究将测试a2/a3 Na+泵和NCX通过间接调节PM和jSR之间空间中的局部[ca 2 +]来调节Ca+信号传导的想法(即,[ca2+]spm),以及Ca ~(2+)的储存和释放。2)目的:研究在250 pm O.D.左右,VSM中SR Ca ~(2+)库是如何组织的,以及哪些转运蛋白参与了VSM的Ca ~(2+)调节。动脉(3)探讨Na+和Ca ~(2+)转运体在肌源性和激动剂诱发的收缩中的作用。在分离的加压动脉中,将监测直径,并使用高亲和力和低亲和力Ca 2+染料Fluo-4和Fluo-5 N,通过共聚焦显微镜测量细胞溶质和SR Ca 2+。将确定NCX、LVGC、SOC以及IP 3和RY敏感性Ca 2+储存的存在和性质。这些转运蛋白如何影响Ca 2+储存和信号在个别细胞,以及它们如何有助于肌张力和激动剂诱发的动脉收缩,将进行调查。将检查正常动脉和来自AS-oligo治疗或具有无效突变的小鼠的转运蛋白水平降低的动脉。Ca 2+信号将与收缩相关,以阐明Na+泵,Ca 2+瞬变和血管张力之间的关系,以获得控制血流和压力的机制的新见解。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MORDECAI P BLAUSTEIN其他文献

MORDECAI P BLAUSTEIN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MORDECAI P BLAUSTEIN', 18)}}的其他基金

Alpha-2 Na+ Pumps, [Ca2+], Arterial Contraction & Hypertension
Alpha-2 Na 泵,[Ca2],动脉收缩
  • 批准号:
    8232831
  • 财政年份:
    2011
  • 资助金额:
    $ 37.13万
  • 项目类别:
Alpha-2 Na+ Pumps, [Ca2+], Arterial Contraction & Hypertension
Alpha-2 Na 泵,[Ca2],动脉收缩
  • 批准号:
    8390477
  • 财政年份:
    2011
  • 资助金额:
    $ 37.13万
  • 项目类别:
Na+, Ca2+, Arterial Contractility & Quabain Hypertension
钠 , 钙 , 动脉收缩力
  • 批准号:
    7088889
  • 财政年份:
    2005
  • 资助金额:
    $ 37.13万
  • 项目类别:
Na+, Ca2+, Arterial Contractility and Ouabain Hypertension
Na , Ca2 , 动脉收缩力 和 哇巴因 高血压
  • 批准号:
    7644870
  • 财政年份:
    2005
  • 资助金额:
    $ 37.13万
  • 项目类别:
Na+, Ca2+, Arterial Contractility and Ouabain Hypertension
Na , Ca2 , 动脉收缩力 和 哇巴因 高血压
  • 批准号:
    7457710
  • 财政年份:
    2005
  • 资助金额:
    $ 37.13万
  • 项目类别:
Na+, Ca2+, Arterial Contractility & Ouabain Hypertension
钠 , 钙 , 动脉收缩力
  • 批准号:
    6855447
  • 财政年份:
    2005
  • 资助金额:
    $ 37.13万
  • 项目类别:
Na+, Ca2+, Arterial Contractility and Ouabain Hypertension
Na , Ca2 , 动脉收缩力 和 哇巴因 高血压
  • 批准号:
    7237244
  • 财政年份:
    2005
  • 资助金额:
    $ 37.13万
  • 项目类别:
Ouabain, Local Ca2+ Control and Myogenic Tone
哇巴因、局部 Ca2 控制和肌源性张力
  • 批准号:
    6968172
  • 财政年份:
    2004
  • 资助金额:
    $ 37.13万
  • 项目类别:
Administrative
行政的
  • 批准号:
    6968177
  • 财政年份:
    2004
  • 资助金额:
    $ 37.13万
  • 项目类别:
PATHWAYS OF INSULIN AND IGFI RECEPTOR SIGNALING
胰岛素和 IGFI 受体信号传导途径
  • 批准号:
    2331471
  • 财政年份:
    1996
  • 资助金额:
    $ 37.13万
  • 项目类别:

相似海外基金

Development of nextgeneration cellular artificial blood vessels for coronary artery bypass surgery using bio-3D printer
使用生物 3D 打印机开发用于冠状动脉搭桥手术的下一代细胞人造血管
  • 批准号:
    23H02991
  • 财政年份:
    2023
  • 资助金额:
    $ 37.13万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Vascular age estimation by carotid artery echocardiography - development of a new method to improve the accuracy
通过颈动脉超声心动图估计血管年龄——开发提高准确性的新方法
  • 批准号:
    23K06864
  • 财政年份:
    2023
  • 资助金额:
    $ 37.13万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Living with Spontaneous Coronary Artery Dissection: A multicentre, patient-informed investigation
自发性冠状动脉夹层的生活:一项多中心、患者知情的调查
  • 批准号:
    481005
  • 财政年份:
    2023
  • 资助金额:
    $ 37.13万
  • 项目类别:
頚動脈プラークに対するスタチンはプラークを安定させるかーNIRSによる分布の変化
他汀类药物治疗颈动脉斑块可以稳定斑块的 NIRS 分布变化吗?
  • 批准号:
    23K15652
  • 财政年份:
    2023
  • 资助金额:
    $ 37.13万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Quantitative assessment of carotid artery plaque vulnerability using dual-energy CT
双能CT定量评估颈动脉斑块易损性
  • 批准号:
    23K14915
  • 财政年份:
    2023
  • 资助金额:
    $ 37.13万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Multi-omics analysis on carotid artery stenosis for the biological mechanism of arteriosclerosis.
颈动脉狭窄的多组学分析动脉硬化的生物学机制。
  • 批准号:
    23K14718
  • 财政年份:
    2023
  • 资助金额:
    $ 37.13万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
The Epigenetic Regulator Prdm16 Controls Smooth Muscle Phenotypic Modulation and Atherosclerosis Risk
表观遗传调节因子 Prdm16 控制平滑肌表型调节和动脉粥样硬化风险
  • 批准号:
    10537602
  • 财政年份:
    2023
  • 资助金额:
    $ 37.13万
  • 项目类别:
Endothelial Cell Reprogramming in Familial Intracranial Aneurysm
家族性颅内动脉瘤的内皮细胞重编程
  • 批准号:
    10595404
  • 财政年份:
    2023
  • 资助金额:
    $ 37.13万
  • 项目类别:
Role of IL-6 trans signaling in atherosclerosis development and late-stage pathogenesis
IL-6反式信号传导在动脉粥样硬化发展和晚期发病机制中的作用
  • 批准号:
    10652788
  • 财政年份:
    2023
  • 资助金额:
    $ 37.13万
  • 项目类别:
The effect of circadian rhythm disruptions on the angiogenic response to hypoperfusion in the AD brain
昼夜节律紊乱对 AD 大脑低灌注血管生成反应的影响
  • 批准号:
    10656133
  • 财政年份:
    2023
  • 资助金额:
    $ 37.13万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了